search
Back to results

Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study) (PREHAB)

Primary Purpose

Heart Failure

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
High-Intensity Interval Training
Sponsored by
Ottawa Heart Institute Research Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Heart Failure focused on measuring Heart failure

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Advanced heart failure and listed for heart transplantation.
  2. Able to perform a symptom-limited exercise test.
  3. Age =>18 years old.
  4. Able to provide informed consent.

Exclusion Criteria:

  1. Currently participating in a structured exercise training program (> 2 times per week)
  2. Status 4 priority listing for heart transplantation.
  3. Myocardial infarction =<7 days.
  4. Heart failure with hemodynamic instability.
  5. Hypertrophic obstructive cardiomyopathy with symptomatic left ventricular outflow tract gradient =>30 mmHg.

Sites / Locations

  • University of Ottawa Heart Institute
  • University Health Network

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Interventional

Non interventional

Arm Description

Group 1. Usual care + High-Intensity Interval Training, Nutritional Workshop, Stress Management Course.

Group 2. Usual care. Patients are encouraged to remain physically active, although they do not participate in a regular structured exercise training program.

Outcomes

Primary Outcome Measures

Change in functional capacity
Change in in functional capacity from baseline to 12 weeks as measured by six-minute walk test distance. Distance walked will be measured in meters.

Secondary Outcome Measures

Change in aerobic power
Measured using expired VO2 gas samples, measured in L/min, ml/kg/min
Change in frailty
Measured by the Fried criteria. Measured by presence of 3 out of 5 frailty symptoms.
Change in general quality of life
Measured by the Short Form 36 Health Survey Questionnaire (SF-36). The SF-36 consists of 8-scaled scores which are the weighted sums of the questions in their section.
Change in disease-specific quality of life
Measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). MLHFQ is a 21-item scale that measures the effects of heart failure on quality of life using a 6-point scale.
Change in depressive symptoms
Measured by the Beck Depression Inventory II (BDI-II). It contains 21-questions, each answer being scored on a scale of 0 to 3.
Change in anxiety
Measured by the Beck Anxiety Inventory (BAI). The BAI is a 21-item validated self-reported measure. A total score is calculated by summing the items; maximum score is 62.
Change in cognitive function
Measured by the Montreal Cognitive Assessment (MOCA). The MOCA is made up of 8 subscales, scores are totaled; maximum score is 30 points.
Change in response to a specific traumatic event
Measured by the Impact of Events Scale- Revised (IES-R). IES-R is 22 items, zero to four scale. Scores above 23 are of concern; scores above 32 indicate a probable diagnosis of PTSD.
Short term post-heart transplantation outcomes
Data collected from medical records: length of hospital stay, adverse events (infection, treated rejection, bleeding, and stroke), survival to hospital discharge, and 30 day hospital readmissions.

Full Information

First Posted
October 27, 2016
Last Updated
April 28, 2021
Sponsor
Ottawa Heart Institute Research Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT02957955
Brief Title
Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study)
Acronym
PREHAB
Official Title
Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation - Addressing Clinical Needs (PREHAB HTx Study)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 1, 2018 (Actual)
Primary Completion Date
February 2, 2020 (Actual)
Study Completion Date
February 2, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ottawa Heart Institute Research Corporation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the addition of high-intensity interval training to the standard pre-heart transplantation clinical care. Participants will be randomised into 2 arms: one arm will receive high-intensity interval training, and the other arm will be encouraged to remain physically active, although they do not participate in a regular structured exercise training program.
Detailed Description
Heart failure affects more than 6.2 million people living in North America. Approximately 10% of patients with heart failure have advanced heart failure. Heart transplantation is an effective life-saving treatment for patients with advanced heart failure. The cardiovascular rehabilitation programs are integral to heart failure management. This study is being done to evaluate, in adults with advanced heart failure awaiting heart transplantation, the effects of cardiovascular rehabilitation (including high-intensity interval training, stress management and nutrition workshops) on functional capacity, aerobic power, frailty, quality of life, and mental health. This study compares pre-transplant cardiovascular rehabilitation with usual pre-transplant care in patients with advanced heart failure awaiting heart transplant. All participants will be randomized into 2 study groups: Group 1 (rehab), and Group 2 (no rehab). Those randomized to Group 1 will receive usual care, 12 weeks of rehab (exercise training, and attend stress and nutrition course through the Heart Failure Clinic and the Division of Prevention and Rehabilitation at the University of Ottawa Heart Institute). Those randomized to Group 2 will receive regular visits through the Heart Failure Clinic; patients are encouraged to remain physically active, although they do not participate in a regular structured exercise training program.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure
Keywords
Heart failure

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Interventional
Arm Type
Experimental
Arm Description
Group 1. Usual care + High-Intensity Interval Training, Nutritional Workshop, Stress Management Course.
Arm Title
Non interventional
Arm Type
No Intervention
Arm Description
Group 2. Usual care. Patients are encouraged to remain physically active, although they do not participate in a regular structured exercise training program.
Intervention Type
Behavioral
Intervention Name(s)
High-Intensity Interval Training
Intervention Description
Participants will complete supervised exercise sessions. Participants will attend on-site high-intensity interval training two times weekly for 12 weeks. Participants will complete six-minute walk test, cardiopulmonary exercise test, and six questionnaires: Short Form 36 Health Survey Questionnaire (SF-36), Minnesota Living with Heart Failure Questionnaire (MLHFQ), Beck Depression Inventory II (BDI-II), Beck Anxiety Inventory (BAI), Montreal Cognitive Assessment (MOCA), and Impact of Events Scale-Revised (IES-R) at baseline (week 1) and follow-up (after 12 weeks of intervention).
Primary Outcome Measure Information:
Title
Change in functional capacity
Description
Change in in functional capacity from baseline to 12 weeks as measured by six-minute walk test distance. Distance walked will be measured in meters.
Time Frame
Baseline to 12 weeks
Secondary Outcome Measure Information:
Title
Change in aerobic power
Description
Measured using expired VO2 gas samples, measured in L/min, ml/kg/min
Time Frame
Baseline to 12 weeks
Title
Change in frailty
Description
Measured by the Fried criteria. Measured by presence of 3 out of 5 frailty symptoms.
Time Frame
Baseline to 12 weeks
Title
Change in general quality of life
Description
Measured by the Short Form 36 Health Survey Questionnaire (SF-36). The SF-36 consists of 8-scaled scores which are the weighted sums of the questions in their section.
Time Frame
Baseline to 12 weeks
Title
Change in disease-specific quality of life
Description
Measured by the Minnesota Living with Heart Failure Questionnaire (MLHFQ). MLHFQ is a 21-item scale that measures the effects of heart failure on quality of life using a 6-point scale.
Time Frame
Baseline to 12 weeks
Title
Change in depressive symptoms
Description
Measured by the Beck Depression Inventory II (BDI-II). It contains 21-questions, each answer being scored on a scale of 0 to 3.
Time Frame
Baseline to 12 weeks
Title
Change in anxiety
Description
Measured by the Beck Anxiety Inventory (BAI). The BAI is a 21-item validated self-reported measure. A total score is calculated by summing the items; maximum score is 62.
Time Frame
Baseline to 12 weeks
Title
Change in cognitive function
Description
Measured by the Montreal Cognitive Assessment (MOCA). The MOCA is made up of 8 subscales, scores are totaled; maximum score is 30 points.
Time Frame
Baseline to 12 weeks
Title
Change in response to a specific traumatic event
Description
Measured by the Impact of Events Scale- Revised (IES-R). IES-R is 22 items, zero to four scale. Scores above 23 are of concern; scores above 32 indicate a probable diagnosis of PTSD.
Time Frame
Baseline to 12 weeks
Title
Short term post-heart transplantation outcomes
Description
Data collected from medical records: length of hospital stay, adverse events (infection, treated rejection, bleeding, and stroke), survival to hospital discharge, and 30 day hospital readmissions.
Time Frame
One year post-heart transplantation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Advanced heart failure and listed for heart transplantation. Able to perform a symptom-limited exercise test. Age =>18 years old. Able to provide informed consent. Exclusion Criteria: Currently participating in a structured exercise training program (> 2 times per week) Status 4 priority listing for heart transplantation. Myocardial infarction =<7 days. Heart failure with hemodynamic instability. Hypertrophic obstructive cardiomyopathy with symptomatic left ventricular outflow tract gradient =>30 mmHg.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer Reed, Ph.D, R.Kin
Organizational Affiliation
Ottawa Heart Institute Research Corporation
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ottawa Heart Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y4W7
Country
Canada
Facility Name
University Health Network
City
Toronto
State/Province
Ontario
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Cardiovascular Prehabilitation in Patients Awaiting Heart Transplantation (PREHAB HTx Study)

We'll reach out to this number within 24 hrs